Gianluca Cavallaro, MD^1*, Anna Grassi, MD^1*, Chiara Pavoni, MSc^1*, Maria Caterina Mico', MD^1*, Alessandro Busca, MD^2*, Irene Maria Cavattoni, MD^3*, Stella Santarone, MD⁴, Carlo Borghero, MD^5*, Attilio Olivieri, MD^6*, Giuseppe Milone, MD⁷, Patrizia Chiusolo, MD^8*, Pellegrino Musto, MD⁹, Riccardo Saccardi, MD¹⁰, Francesca Patriarca, MD, Prof^11*, Fabrizio Pane, MD¹², Giorgia Saporiti, MD^13*, Paolo Rivela, MD^14*, Elisabetta Terruzzi, MD^15*, Raffaella Cerretti, MD^16*, Giuseppe Marotta, MD^17*, Angelo Michele Carella, MD^18*, Arnon Nagler, MD¹⁹, Domenico Russo, MD²⁰, Paolo Corradini, MD²¹, Paolo Bernasconi, MD²², Anna Paola Iori, MD^23*, Luca Castagna, MD^24*, Nicola Mordini, MD^25*, Elena Oldani, MSc^1*, Carmen Di Grazia, MD^26*, Andrea Bacigalupo, MD²⁷ and Alessandro Rambaldi, MD²⁸

¹Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
²SSD Trapianto Cellule Staminali, AOU Citta' della Salute e della Scienza, Torino, Italy
³Ematologia e TMO, Ospedale di Bolzano, Azienda Sanitaria Alto Adige, Bolzano, Italy
⁴Ospedale Civile, Pescara, Italy
⁵Dipartimento di Ematologia, Ospedale San Bortolo, Vicenza, Italy
⁶Università Politecnica Delle Marche, Ancona, Italy
⁷Hematology and BMT Unit, Azienda Ospedaliero Universitaria Policlinico "G.Rodolico-San Marco", Catania, Italy
⁸Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
⁹Hematology and Bone Marrow Transplantation Unit - AOUC Policlinico, Department of Emergency and Organ Transplantation, “Aldo Moro” University, Bari, Italy
¹⁰Azienda Ospedaliero Universitaria Careggi, Firenze, Italy
¹¹Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy
¹²Dipartimento Medicina Clinica e Chirurgia, UOC Ematologia e Trapianti di Midollo, Azienda Ospedaliera Universita Federico II, Napoli, Italy
¹³Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Milan, Italy
¹⁴Division of Hematology, A.O. SS Antonio e Biagio and Cesare Arrigo, Alessandria, Italy
¹⁵Hematology Division, San Gerardo Hospital, Monza, Italy
¹⁶Hematology Division-Stem Cell Transplant Unit, Policlinico Tor Vergata, Rome, Italy
¹⁷Azienda Ospedaliera Universitaria Senese, Siena, ITA
¹⁸Ematologia e Centro Trapianto CSE, Fondazione Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
¹⁹Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel
²⁰Unit of Blood Diseases and Stem Cell Transplantation, University of Brescia, ASST Spedali Civili, Brescia, Italy
²¹Università degli Studi di Milano and Fondazione Istituti di Ricovero e Cura a Carattere Scientifico (IRCSS) Istituto Nazionale dei Tumori, Milan, Italy
²²HSCT Unit, UOC Ematologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
²³Hematology, Department of Translational and Precision Medicine, AOU Policlinico Umberto I, Sapienza University of Rome, Roma, Italy
²⁴UOSD Trapianto di Midollo, Ospedale Villa Sofia Cervello, Palermo, Italy
²⁵Santa Croce e Carle Hospital, Division of Haematology, Cuneo, Italy
²⁶UO Ematologia e Terapie Cellulari, IRCCS Ospedale Policlinico San Martino, Genova, Italy
²⁷Ematologia, Fondazione Universitaria Policlinico Gemelli IRCCS, Rome, Italy
²⁸Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy

Sara J. Schonfeld^1*, Bryan Valcarcel, MD^1*, Christa L. Meyer, MS^2*, Ann M Brunson, MS^3*, Julianne J.P. Cooley, MS^4*, Renata Abrahao, MD, PhD, MSc³, Ted Wun, MD³, Jeffery Auletta, MD^2,5*, Lori Muffly, MD, MS⁶, Theresa H.M. Keegan, PhD³ and Lindsay M. Morton, PhD¹

¹Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD
²CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN
³Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA
⁴California Cancer Reporting and Epidemiologic Surveillance Program, University of California Davis Comprehensive Cancer Center, Sacramento, CA
⁵Divisions of Hematology/Oncology/BMT and Infectious Diseases, Nationwide Children’s Hospital, Columbus, OH
⁶Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA

Nico Gagelmann^1*, Anita Badbaran^1*, Christine Wolschke, MD^2*, Raissa Adjallé^3*, Dietlinde Janson, MD^2*, Carolina Berger^4*, Evgeny Klyuchnikov^2*, Boris Fehse, PhD^4*, Francis A. Ayuk, MD^2* and Nicolaus Kroeger, MD²

¹University Medical Center Hamburg-Eppendorf, Department of Stem Cell Transplantation, Hamburg, Germany
²Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
³University Medical Center Hamburg-Eppendorf, Hamburg, DEU
⁴Department of Stem Cell Transplantation, Research Department Cell and Gene Therapy, University Medical Center Hamburg-Eppendorf, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Christopher Graham, MD^1,2, Runhua Shi, PhD^1* and Gerhard C. Hildebrandt, MD^2,3

¹Louisiana State University Health Science-Shreveport, Shreveport, LA
²Department of Internal Medicine, Division of Hematology/BMT, University of Kentucky, Lexington, KY
³University of Missouri-Ellis Fischel Cancer Center, Columbia, MO

Luxin Yang^1,2,3,4*, Xiaoyu Lai, M.D.^1,2,3,4*, Ting Yang, MD, PhD⁵, Ying Lu^6*, Lizhen Liu, M.D.^1,2,3,4*, Jimin Shi, M.D.^1,2,3,4*, Yanmin Zhao^2,3,4,7*, Yibo Wu, M.D.^1,2,3,4*, Yi Chen, MD^8*, Jian Yu, Ph.D.^1,2,3,4*, Haowen Xiao^3,4,9*, Guifang Ouyang, MD^10*, Jinhua Ren^5*, Junjie Cao^6*, Yongxian Hu, M.D., Ph.D.^2,3,4,11*, Yamin Tan, MD^2,3,4,7*, Zhen Cai, PhD, MD^2,3,4,12*, He Huang^2,3,7,11 and Yi Luo, M.D.^1,2,3,4*

¹Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, Hangzhou, China
²Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China
³Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou 311121, China, Hangzhou, China
⁴Institute of Hematology, Zhejiang University, Hangzhou, China
⁵Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, Fuzhou, China, Fuzhou, China
⁶The affiliated people’s hospital of Ningbo University, Ningbo, China, Ningbo, China
⁷Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁸The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
⁹Department of Hematology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China, Hangzhou, China
¹⁰Ningbo City first hospital, Ningbo, China
¹¹Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
¹²Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China

Sawa Ito, MD¹, Elizabeth F Krakow, MD, MSc², Kedwin Ventura, M.S.^1*, Amy Rodger, BSN, RN^3*, Emily Geramita, MD, PhD¹, Erika Moore, MD^4*, Geoffrey R Hill, MD² and Warren D Shlomchik, MD¹

¹Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA
²Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
³UPMC Hillman Cancer Center, Pittsburgh, PA
⁴Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh

Megan Hogg, BSN RN, Grad Cert (OncNurs)^1*, Jacinta Perram, MBBS^1,2, Abir Bhattacharyya, MBBS, FRACP, FRCPA^1*, Ian Bilmon, BMBS, BSc, FRACP, FRCPA, MPhil^1,3*, Emily Blyth, B. Med(Hons), FRACP, FRCPA, PhD^4,5*, John Kwan, MBBS, FRACP, FRCPA^6*, Kenneth P. Micklethwaite, MBBS, PhD, FRACP, FRCPA^2,6,7,8*, Shyam Panicker, MBBS, MD, MRCP, FRACP, FRCPA^6*, Amanda Seabrook, MBBS, Grad Dip PH, FRACP^9* and David J Gottlieb, MD, MBBS, FRACP, FRCPA^1,10,11*

¹Blood Transplant and Cell Therapies Program, Westmead Hospital, Sydney, NSW, Australia
²Faculty of Medicine, University of Sydney, Sydney, NSW, Australia
³Sydney Blood Specialists, Sydney Adventist Hospital, Sydney, NSW, Australia
⁴Westmead Institute for Medical Research, The University of Sydney, Sydney, NSW, Australia
⁵Blood Transplant and Cell Therapies, Westmead Hospital, Sydney, NSW, Australia
⁶Blood Transplant and Cellular Therapies Program, Westmead Hospital, Sydney, NSW, Australia
⁷Westmead Institute of Medical Research, University of Sydney, Sydney, NSW, Australia
⁸Blood Transplant and Cell Therapies Laboratory, NSW Health Pathology, Westmead, NSW, Australia
⁹Department of Endocrinology, Westmead Hospital, Sydney, NSW, Australia
¹⁰Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia
¹¹Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia

Pierre Peterlin, MD^1*, Marie C Bene, PharmD, DPhil^2*, Maxime Jullien, MD^3*, Thierry Guillaume, MD, PhD^3*, Amandine Le Bourgeois, PhD^1*, Alice Garnier, MD^1*, Camille Debord, PharmD^2*, Marion Eveillard^2* and Patrice Chevallier, MD¹

¹Clinical Hematology, Nantes University Hospital, Nantes, France
²Hematology Biology, Nantes University Hospital, Nantes, France
³Hematology Department, Nantes University Hospital, Nantes, France

Bryan Valcarcel, MD^1*, Sara J. Schonfeld^1*, Christa L. Meyer, MS^2*, Ann M Brunson, MS^3*, Julianne J.P. Cooley, MS^4*, Renata Abrahao, MD, PhD, MSc³, Ted Wun, MD³, Jeffery Auletta, MD^2,5*, Lori Muffly, MD, MS⁶, Theresa H.M. Keegan, PhD³ and Lindsay M. Morton, PhD¹

¹Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD
²CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN
³Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA
⁴California Cancer Reporting and Epidemiologic Surveillance Program, University of California Davis Comprehensive Cancer Center, Sacramento, CA
⁵Divisions of Hematology/Oncology/BMT and Infectious Diseases, Nationwide Children’s Hospital, Columbus, OH
⁶Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA

Jason Yeh, PharmD^1*, Rima M. Saliba, PhD^2*, Christopher Wang, PharmD^1*, Zhou Fang, PharmD^1*, Bradley Figgins, PharmD^1*, Sairah Ahmed, MD³, Musa Yilmaz, MD⁴, Naval Daver, MD⁴, Rohtesh S. Mehta, MD², Gheath Alatrash, PhD, DO², David Marin, MD², Uday R Popat, MD², Richard E Champlin, MD², Elizabeth J Shpall, MD² and Betul Oran, MD, MS²

¹Division of Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Lymphoma/Myeloma and Stem Cell Transplantation, MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Cuiyan Zhou^1*, Fengmei Zheng^2*, Lanping Xu^3*, Xiaohui Zhang^4*, Yingjun Chang^5*, Xiao-Dong Mo^6*, Yuqian Sun^7*, Yu Wang^8* and Xiao-Jun Huang⁷

¹Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China
²Peking University People’s Hospital, Beijing, China
³Peking University Institute of Hematology, Beijing, China
⁴Peking University people hospital, Beijing, China
⁵Peking University Institute of Hematology, Peking University People's Hospital, Beijing, China
⁶Peking University People’s Hospital, Beijing, Beijing, China
⁷Peking University People’s Hospital & Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
⁸Peking University People's Hospital, Peking University Institute of Hematology, China, Beijing, China

Shuang Fan^1*, Hao-Yang Hong^2,3*, Xin-Yu Dong^4*, Lan-Ping Xu^5*, Xiao-hui Zhang^6*, Yu Wang^7*, Chen-Hua Yan^8*, Huan Chen^5*, Yu-Hong Chen^9*, Wei Han^5*, Fengrong Wang, MD^8*, Jing-Zhi Wang^9*, Kaiyan Liu, MD, PhD¹⁰, Meng-Zhu Shen^11*, Xiao-jun Huang⁸, Shen-Da Hong^12* and Xiao-Dong Mo^6*

¹Peking University People's Hospital, Beijing, AL, China
²The Chinese University of Hong Kong, Shenzhen, China
³Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China
⁴Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
⁵Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of HSCT, Peking University, Beijing, China
⁶Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
⁷Department of Hematology, Peking University People’s Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China
⁸Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
⁹Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Collaborative Innovation Center of Hematology, Beijing, China
¹⁰Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematology Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
¹¹Peking University People's Hospital, Peking University Institute of Hematology,, Beijing, CHN
¹²National Institute of Health Data Science at Peking University, Peking University Health Science Center, Beijing, China

Zhihui Li^1*, Keyan Yang, Master^2*, Qinlong Zheng^2*, Xianxuan Wang^3*, Fan Wu^1*, Jing Li^1*, Xiaopei Wen^1*, Caiyan Zhang, PHD^4*, Jingjing Wang^5*, Yanzhi Song^1*, Yongqiang Zhao^1* and Tong Wu, MD⁶

¹Bone Marrow Transplantation, Beijing Boren Hospital, Beijing, China
²Medical Laboratory, Beijing Boren Hospital, Beijing, China
³Beijing Boren Hospital, Beijing, Iowa, CHN
⁴Bone Marrow Transplantation, Beijing Borenhospital, Beijing, China
⁵Department of Hematology, Beijing Boren Hospital, Beijing, China
⁶Bone Marrow Transplantation, Beijing Boren Hospital, Beijing, IN, China

Oren Pasvolsky, MD^1,2,3*, Rima M. Saliba, PhD^2*, Celina Ledesma^2*, Uday R Popat, MD², Amin M Alousi, MD², Amanda L. Olson, MD², Betul Oran, MD, MSc^2*, Chitra Hosing, MD², Qaiser Bashir, MD², Muzaffar H Qazilbash, MD², Nicholas Short, MD⁴, Farhad Ravandi, MD⁵, Richard E Champlin, MD², Elizabeth J Shpall, MD² and Partow Kebriaei, MD²

¹Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Tel Aviv, Israel
²Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
³Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
⁴Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX